8-K: Current report
8-K: Current report
8-K: Current report
8-K: American Oncology Network, Inc. Announces First Quarter 2024 Financial Results
8-K: Current report
POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
8-K: Current report
American Oncology Network | 8-K: Current report
American Oncology Network | 8-K: American Oncology Network, Inc. (“AON”) Announces Fourth Quarter and Full Year 2023 Financial Results
American Oncology Network | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
American Oncology Network | 8-K: Current report
American Oncology Network | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
American Oncology Network | 8-K: American Oncology Network, Inc. Announces Third Quarter 2023 Financial Results
American Oncology Network | S-1: General form for registration of securities under the Securities Act of 1933
American Oncology Network | 8-K: Current report
American Oncology Network | 8-K: Current report
American Oncology Network | 8-K: Current report
Digital Transformation | 8-K: Current report
Digital Transformation | 8-K: Current report
Digital Transformation | 8-K: Current report
No Data